ERA Access to Documents in the EU in the field of Pharmaceutical Law – Recent CJEU Rulings
Brian Kelly

Access to Documents in the EU in the field of Pharmaceutical Law – Recent CJEU Rulings

The e-presentation critically analyses the impact of three recent rulings by the General Court related to the European Medicines Agency’s policy of access to documents. It gives a useful indication for applicants as to what might be considered in the future as commercially confidential information and offers useful advice on the drafting of clinical trial documents to be submitted to the EMA.

Brian Kelly

Free version

This version of the e-presentation shows the complete e-presentation.

No certificate can be provided for using this version.
 
 

Start

Premium version

The premium version offers free navigation, downloadable slides, MP3 version, offline video version and the seminars background documentation as additional value.

It is also eligble for the acquisition of CPD points.

Buy